Yoshihiro Koseki
- Toxicology top 5%
- Genetics top 5%
- Estrogen and related hormone effects 7
- Oncology top 10%
- Drug Transport and Resistance Mechanisms 3
- Metal complexes synthesis and properties 2
-
- Hearing, Cochlea, Tinnitus, Genetics 4
-
- Hearing Loss and Rehabilitation 5
-
- Cancer therapeutics and mechanisms 4
-
- Vestibular and auditory disorders 3
-
- Effects and risks of endocrine disrupting chemicals 2
- Co-authors
- William McGuireKathryn B. HorwitzMervyn IsraelDavid T. ZavaRamakrishnan Ayloor SeshadriS KirschenbaumFernando C. GiulianiM Potmĕsil
- Cited by
- ToxicologyGeneticsOncology
- Journals
- Endocrinology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United StatesJapan
In The Last Decade
Yoshihiro Koseki
22 papers receiving 780 citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Toxicology 58
- Genetics 383
- Oncology 246
- Cancer Research 101
- Sensory Systems 25
Countries citing papers authored by Yoshihiro Koseki
This map shows the geographic impact of Yoshihiro Koseki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshihiro Koseki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshihiro Koseki more than expected).
Fields of papers citing papers by Yoshihiro Koseki
This network shows the impact of papers produced by Yoshihiro Koseki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshihiro Koseki. The network helps show where Yoshihiro Koseki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Yoshihiro Koseki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 0 | |
| 2 | 2007 | 16 | |
| 3 | 2000 | 13 | |
| 4 | 2000 | 10 | |
| 5 | 1994 | 5 | |
| 6 | 1990 | 1 | |
| 7 | 1990 | 22 | |
| 8 | 1989 | 8 | |
| 9 | DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. | 1989 | 202 |
| 10 | 1987 | 0 | |
| 11 | 1987 | 17 | |
| 12 | 1987 | 18 | |
| 13 | Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue. | 1987 | 5 |
| 14 | Prolactin regulation of estrogen and progesterone receptors in normal and neoplastic mouse mammary tissue. | 1987 | 7 |
| 15 | 1982 | 8 | |
| 16 | 1979 | 15 | |
| 17 | 1977 | 76 | |
| 18 | 1977 | 39 | |
| 19 | 1974 | 8 | |
| 20 | 1973 | 1 |
About Yoshihiro Koseki
Yoshihiro Koseki is a scholar working on Sensory Systems, Otorhinolaryngology, Neurology, Oncology and Toxicology, having authored 25 papers that have together received 836 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (7 papers), Hearing Loss and Rehabilitation (5 papers), Hearing, Cochlea, Tinnitus, Genetics (4 papers), Cancer therapeutics and mechanisms (4 papers), Drug Transport and Resistance Mechanisms (3 papers), Vestibular and auditory disorders (3 papers), Effects and risks of endocrine disrupting chemicals (2 papers) and Metal complexes synthesis and properties (2 papers). The work is most often cited by research in Toxicology (58 citations), Genetics (383 citations), Oncology (246 citations), Cancer Research (101 citations) and Sensory Systems (25 citations). Yoshihiro Koseki has collaborated with scholars based in United States and Japan. Frequent co-authors include William McGuire, Kathryn B. Horwitz, Mervyn Israel, David T. Zava, Ramakrishnan Ayloor Seshadri, S Kirschenbaum, Fernando C. Giuliani, M Potmĕsil, R Silber and Leroy F. Liu. Their work appears in journals such as Endocrinology, Cancer Chemotherapy and Pharmacology, Journal of Pharmacology and Experimental Therapeutics, Cancer Treatment Reviews and Anti-Cancer Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.